Publications

Search our bibliography using the filters on the right-hand side.

Displaying 1 through 19 of 19 publications.

Berchuck A, Schildkraut JM, Wenham RM, Calingaert B, Ali S, Henriott A, Halabi S, Rodriguez GC, Gertig D, Purdie DM, Kelemen L, Spurdle AB, Marks J, Chenevix-Trench G. Progesterone receptor promoter +331A polymorphism is associated with a reduced risk of endometrioid and clear cell ovarian cancers. Cancer Epidemiol Biomarkers Prev. 2004 Dec 1;13(12):2141-7.

Schmidt RA, Ackerman SJ, Newstead GM, Quam JP, Mordin MM, Anastassopoulos K, Nishikawa RM. Comparative feature analysis of computed radiography for mammography (CRM) soft copy display vs. crm hard copy film: an observer performance study. Poster presented at the 90th Scientific Assembly and Annual Meeting of the Radiology Society of North America; November 2004.

Johannes CB, Schneider GA, Walker AM, Viveash D, Wallis WJ. Increased incidence of lymphoma among patients with rheumatic diseases based on automated insurance claims information. Presented at the 20th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 22, 2004. Bordeaux, France. [abstract] Pharmacoepidemiol Drug Saf. 2004 Sep 23; 13:S239.

Harris DH, Bates JH, Cress R, Tabnak F, Wright WE. Stage of breast cancer diagnosis among medically underserved women in California receiving mammography through a state screening program. Cancer Causes Control. 2004 Sep;15(7):721-9.

Bradbury BD, Lash TL, Kaye JA, Jick SS. Tamoxifen and cataracts: a null association. Breast Cancer Res Treat. 2004 Sep;87(2):189-96.

Knight C, Hind D, Brewer N, Abbott V. Rituximab (MabThera) for aggressive non-Hodgkin's lymphoma: systematic review and economic evaluation. Health Technol Assess. 2004 Sep;8(37):1-82.

Midkiff KD. An introduction to transact structured query language. Poster presented at the Bi-Annual Meeting of the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Steering Committee; September 2004. Santa Fe, NM.

Moorman PG, Skinner CS, Evans JP, Newman B, Sorenson JR, Calingaert B, Susswein L, Crankshaw TS, Hoyo C, Schildkraut JM. Racial differences in enrolment in a cancer genetics registry. Cancer Epidemiol Biomarkers Prev. 2004 Aug 1;13(8):1349-54.

Heyes A. Clinical trial experience with Functional Assessment of Cancer Therapy—Lung in conventional and targeted non—small cell lung cancer therapy. Semin Oncol. 2004 Jun 1;31(Suppl. 9):16-22.

Havrilesky LJ, Leath CA, Huh W, Calingaert B, Bentley RC, Soper JT, Secord AA. Radical hysterectomy and pelvic lymphadenectomy for stage IB2 cervical cancer. Gynecol Oncol. 2004 May 1;93(2):429-34.

Midkiff KD. Reactogenicity monitoring and adverse event reporting. Poster presented at the Guanacaste Epidemiology Project; May 2004.

Midkiff KD. Improvements to the integrated data entry and administration system (IDEAS). Poster presented at the Bi-Annual Meeting of the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Steering Committee; March 2004. San Diego, CA.

Kaye JA, Jick H. Statin use and cancer risk in the general practice research database. Br J Cancer. 2004 Feb 9;90(3):635-7.

Midkiff KD. Webcasting training for the integrated data entry and administration system. Presented at the National Lung Screening Trial Data Management Consortium; February 2004.

Copley-Merriman K, Jackson J, Boyer JG, Cappelleri J, DeMarinis R, DiCesare J. Industry perspective regarding outcomes research in oncology. New York: NY. Cambridge University Press; 2004. p.623-38.

Beard SM, Wall L, Gaffney L, Sampson F. Aggressive non-Hodgkin's lymphoma: economics of high-dose therapy. Pharmacoeconomics. 2004 Jan 1;22(4):207-24.

Poole C, Rothman KJ, Dreyer NA. Leukemia near Pilgrim nuclear-power plant, Massachusetts. Lancet. 1988 Dec 3;332(8623):1308. doi: 10.1016/S0140-6736(88)92915-7

Dreyer NA, Loughlin JE, Lanes SF, Rothman KJ. Mortality among employees of a nuclear power company. J Occup Environ Med. 1988 Jan 1;30(12):988-9.

Rothman KJ, Keller AZ. The effect of joint exposure to alcohol and tobacco on risk of cancer of the mouth and pharynx. J Chronic Dis. 1972 Dec;25(12):711-6.